{
  "docId": "019dd923-622c-750b-8b9b-7e7228555e88",
  "docSlug": "36c903ba19aa",
  "documentTitle": "Allergan, Inc. (AGN)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2014-04-22 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.70665085,
  "pageNumber": 23,
  "pageCount": 110,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "before_after",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 5,
  "notes": "The chart uses a bridge-like structure to reclassify 85% of revenue as 'durable' by excluding the 15% 'Patent Cliff Rx' portion.",
  "elementsJson": [
    "headline_text",
    "callout_box",
    "bar_chart_stacked",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/23",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-23",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Durable healthcare products are more comparable to high-margin consumer products than to traditional, patented pharma products",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-f5d3-71df-9942-51e1f4f381ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.6,
        "x": 0.2,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Revenue composition bridge showing 100% total revenue reduced by 15% patent cliff to arrive at 85% durable products",
      "attrs": null,
      "subkind": "waterfall-bridge",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6fa5ddce-151c-446a-ae45-d43e3a02c1c8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "2014E Revenue: 85%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-f5d3-71df-9942-5724ad3e0595",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.4,
        "x": 0.1,
        "y": 0.51
      },
      "kind": "source-note",
      "text": "Source: Valeant Presentations, April 22, 2014 and January 14, 2014 at JPMorgan Conference",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bcc9d8d5-273a-4a61-bc8e-8b3d0739bd48",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.1,
        "y": 0.13
      },
      "kind": "title",
      "text": "Durable healthcare products are more comparable to high-margin consumer products than to traditional, patented pharma products",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bdade9d1-01de-4c2c-bf0f-4b6591779ad9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.1,
        "y": 0.1
      },
      "kind": "title",
      "text": "The Vast Majority of Valeant's Revenue is Durable",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "97b02d85-efb8-43b6-b23b-1a0dd1835de6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before/after framing",
      "slug": "before-after-framing",
      "agent": null,
      "layer": "slide",
      "matchId": "1f74b33f-69b1-4491-b05b-dcc9ad898244",
      "evidence": "type: before_after",
      "confidence": 0.7
    },
    {
      "name": "Waterfall / value bridge",
      "slug": "waterfall-bridge",
      "agent": null,
      "layer": "slide",
      "matchId": "25454d09-f135-458e-90de-bae03ac29f03",
      "evidence": "chart/waterfall-bridge: Revenue composition bridge showing 100% total revenue reduced by 15% patent cliff to arrive at 85% durable products",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "e54f3f9a-914c-419a-9878-f2a3c76097ce",
      "evidence": "Uses a waterfall bridge to reframe revenue risk",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}